Developer docs
API playgroundTry for free, no card

Search company profiles

Camber Pharmaceuticals

Full company profile

uuid0007927

Namestring
Camber Pharmaceuticals
Legal namestring
Camber Pharmaceuticals, Inc.
Company typeenum
Private
Founded yearint
2007
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersPiscataway, United States
HQ citystring
Piscataway
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, specialty injectables, oncology generics, OTC medications, vertical integration API
Industry4 codes
PRIMARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAIADAB
Cold, Flu & Cough Remedies
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIACAC
Neurology & CNS Specialty Pharmaceuticals
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code3 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Generic Pharmaceuticals
Social media profiles2 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Generic Rx Product Sales
TypeOne Time License
Description

Sale of generic prescription pharmaceutical products including tablets, capsules, injections, and oral solutions across multiple therapeutic categories including cardiovascular, oncology, HIV/AIDS, and specialty medications.

camberpharma.com
2Specialty Generic Products
TypeOne Time License
Description

Sale of specialty generic medications including injectables and oncology products to hospitals, clinics, government facilities, and institutional partners.

camberpharma.com
3Over-the-Counter (OTC) Products
TypeOne Time License
Description

Sale of OTC medications through retail partners and direct supply to consumers.

camberpharma.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Copay Assistance Program
ModelOtherBilling cadencePay-as-you-go
Notes

Copay cards available for select specialty medications to reduce patient out-of-pocket costs

camberpharma.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Camber Specialty
Description

Specialty generic medications division supporting hospitals, clinics, government facilities, and institutional partners with high-quality generic choices including injectables and oncology medications

camberpharma.com
+1 more record
Core offering1 text field

Camber Pharmaceuticals manufactures, markets, and distributes a portfolio of nearly 200 generic prescription (Rx), specialty, and over-the-counter (OTC) pharmaceutical products in the United States. The company operates three divisions—Camber Pharmaceuticals (Rx generics), Camber Specialty (injectables and oncology), and Camber Consumer Care (OTC)—supported by parent company Hetero's vertically integrated supply chain from key starting materials to active pharmaceutical ingredients to finished dosage forms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Supply service levels consistently exceed 95% for primary positions
+3 more records
Product and service14 records
1Camber Pharmaceuticals (Rx Generics)
CategoryGeneric Rx Pharmaceuticals
Description

Primary prescription generic pharmaceutical division offering a comprehensive portfolio of cost-effective generic medications across multiple therapeutic categories including cardiovascular, oncology, antiviral, neurological, and acute care treatments. Targeted at wholesalers, distributors, hospitals, and retail pharmacies.

2Camber Specialty (Injectables and Oncology)
CategorySpecialty Generic Pharmaceuticals
Description

Specialty pharmaceutical division focused on injectable and oncology medications, supporting hospitals, clinics, government facilities, and institutional partners with high-quality specialty generic choices.

3Camber Consumer Care (OTC)
CategoryOver-the-Counter Pharmaceuticals
Description

Over-the-counter pharmaceutical division delivering high-quality OTC medications, providing focused and reliable supply of products to retail partners for consumer purchase.

4Nitazoxanide Tablets
CategoryGeneric Rx Pharmaceuticals
Description

Antiprotozoal medication indicated for treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum infections. Generic to Alinia. Available in 500mg strength, 6 count bottles.

5Cisatracurium Besylate Injection, USP
CategorySpecialty Generic Pharmaceuticals
Description

Nondepolarizing neuromuscular blocker indicated as adjunct to general anesthesia for tracheal intubation and skeletal muscle relaxation during surgery, and for mechanical ventilation in ICU. Generic to Nimbex.

6Olmesartan Medoxomil and Hydrochlorothiazide Tablets
CategoryGeneric Rx Pharmaceuticals
Description

Combination angiotensin II receptor blocker (ARB) and thiazide diuretic for treatment of hypertension to lower blood pressure and reduce risk of cardiovascular events. Generic to Benicar HCT.

7Plerixafor Injection
CategorySpecialty Generic Pharmaceuticals
Description

Hematopoietic stem cell mobilizer used with G-CSF to mobilize stem cells for collection and subsequent autologous transplantation in non-Hodgkin's lymphoma and multiple myeloma patients. Generic to Mozobil.

8Sirolimus Oral Solution
CategorySpecialty Generic Pharmaceuticals
Description

mTOR inhibitor immunosuppressant for prophylaxis of organ rejection in renal transplant patients aged 13 and older, used with cyclosporine and corticosteroids. Generic to Rapamune.

9Avanafil Tablets
CategoryGeneric Rx Pharmaceuticals
Description

Phosphodiesterase 5 (PDE5) inhibitor for treatment of erectile dysfunction. Generic to Stendra. Available in 50mg, 100mg, and 200mg strengths in 30 count bottles.

10Erlotinib Tablets
CategorySpecialty Generic Pharmaceuticals
Description

Kinase inhibitor for treatment of metastatic non-small cell lung cancer and pancreatic cancer (in combination with gemcitabine). Generic to Tarceva.

11Capecitabine Tablets, USP
CategorySpecialty Generic Pharmaceuticals
Description

Nucleoside metabolic inhibitor for adjuvant treatment of Stage III colon cancer, perioperative rectal cancer, and treatment of metastatic colorectal, breast, gastric, esophageal, gastroesophageal junction, and pancreatic cancers. Generic to Xeloda.

12Decitabine for Injection
CategorySpecialty Generic Pharmaceuticals
Description

Nucleoside metabolic inhibitor for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS. Generic to Dacogen.

13Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP
CategorySpecialty Generic Pharmaceuticals
Description

Diagnostic contrast agent for radiographic examination of gastrointestinal tract segments and adjunct contrast enhancement in CT imaging. Generic to Gastrografin.

14Copay Assistance Program
CategoryPatient Access Program
Description

Patient assistance program offering copay cards for select specialty medications including Dabigatran, Deferasirox, Dimethyl Fumarate, Droxidopa, Eltrombopag, Fingolimod, Lenalidomide, Nilotinib, Pirfenidone, Pomalidomide, Sapropterin, and Sodium Oxybate to reduce out-of-pocket costs.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hetero is the parent company and strategic partner of Camber Pharmaceuticals. Hetero is one of the world's largest manufacturers of APIs and finished dosage forms, based in Hyderabad, India. Hetero provides Camber with vertical integration capabilities from KSMs to APIs to FDFs, R&D support with 1,200+ researchers, and access to 45 manufacturing facilities (8 dedicated to US market). Hetero employs 32,000+ associates and has presence in 140+ countries.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Hetero partnered with the Clinton Foundation to supply antiretroviral (ARV) medicines to underprivileged countries, particularly in Africa.

3Healthcare Distribution Partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Camber works with healthcare distribution partners including major distributors to ensure reliable product availability and improve operational efficiency across the healthcare supply chain.

camberpharma.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Ascent Pharmaceuticals, Inc. of Central Islip, New York is Camber's sister company engaged in development and manufacturing of controlled substance generics including Oxycodone, Dronabinol, and Fentanyl products.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The world's largest generic drug manufacturer with a broad US portfolio across oral solids, injectables, and specialty. Directly comparable because both compete head-to-head on Day-1 generic launches and institutional/wholesaler channels, though Teva operates at vastly larger global scale.

2Sandoz (Novartis)
TypeBroad incumbent
Description

Sandoz is one of the top global generic and biosimilar players with a large US generic portfolio, including injectables and oral solids. Highly comparable as both compete for Day-1 ANDA launches and wholesaler contracts; Sandoz also has vertically integrated manufacturing.

TypeBroad incumbent
Description

Formed from the Mylan-Upjohn combination, Viatris is a major US generics supplier with a deep portfolio spanning retail, hospital, and specialty channels. Comparable because both companies sell broad-line generics through the same wholesalers and institutional buyers.

TypeDirect peer
Description

Apotex is a privately held Canadian generic pharmaceutical manufacturer with significant US sales, vertically integrated API-to-FDF operations, and a broad product portfolio. Closely comparable to Camber given its private status, vertical integration, and aggressive ANDA pipeline.

TypeDirect peer
Description

US arm of India's Aurobindo Pharma, supplying generics across oral solids, injectables, and specialty. Comparable to Camber given Indian-parent vertical integration model, broad US portfolio, and shared reliance on ANDA pipelines.

6Sun Pharmaceutical Industries
TypeDirect peer
Description

Sun Pharma's US subsidiary (including the former Taro Pharmaceutical) supplies a broad range of generic Rx and specialty products. Highly comparable to Camber in business model, scale of US generics operations, and India-backed vertical integration.

TypeDirect peer
Description

Lupin's US business sells generic oral solids, injectables, and specialty products with strong institutional relationships. Comparable to Camber as both are India-headquartered generic companies focused on US Day-1 launches and high-ANDA approval velocity.

TypeDirect peer
Description

Dr. Reddy's US generics arm supplies Rx, OTC, and specialty products across therapeutic categories including oncology and CNS. Comparable because both rely on parent-company vertical integration, broad ANDA pipelines, and large wholesaler relationships.

TypeDirect peer
Description

Zydus is the US generics subsidiary of India's Cadila Healthcare, offering oral solids, injectables, and specialty generics. Comparable to Camber given shared India-parent structure, US Day-1 launch focus, and broad institutional/retail channels.

TypeRegional player
Description

Endo's generics segment (including Par Pharmaceutical) supplies US generics, sterile injectables, and specialty products through institutional channels. Comparable to Camber in US generics and injectables exposure, though Endo has historically focused more on branded specialty and 505(b)(2) opportunities.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Camber Pharmaceuticals

Generic Pharmaceuticalscamberpharma.com

Camber Pharmaceuticals firmographics

Firmographics
Name
Camber Pharmaceuticals
Legal name
Camber Pharmaceuticals, Inc.
Website
https://camberpharma.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Camber Pharmaceuticals industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIABAI
Contract Development & Manufacturing for Generics (CDMO/CMO)
SECONDARYHLAIADAB
Cold, Flu & Cough Remedies
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
SECONDARYHLAIACAC
Neurology & CNS Specialty Pharmaceuticals
SECONDARYCRADAMAD
Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Generic pharmaceuticals
  • Specialty injectables
  • Oncology generics
  • OTC medications
  • Vertical integration API

Where Camber Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Piscataway
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Camber Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Generic Rx Product Sales: Sale of generic prescription pharmaceutical products including tablets, capsules, injections, and oral solutions across multiple therapeutic categories including cardiovascular, oncology, HIV/AIDS, and specialty medications.
  2. Specialty Generic Products: Sale of specialty generic medications including injectables and oncology products to hospitals, clinics, government facilities, and institutional partners.
  3. Over-the-Counter (OTC) Products: Sale of OTC medications through retail partners and direct supply to consumers.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goCopay Assistance Program

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Camber Pharmaceuticals product offering

Product offering

Core offering

Camber Pharmaceuticals manufactures, markets, and distributes a portfolio of nearly 200 generic prescription (Rx), specialty, and over-the-counter (OTC) pharmaceutical products in the United States. The company operates three divisions—Camber Pharmaceuticals (Rx generics), Camber Specialty (injectables and oncology), and Camber Consumer Care (OTC)—supported by parent company Hetero's vertically integrated supply chain from key starting materials to active pharmaceutical ingredients to finished dosage forms.

Differentiator

Problem solved

Functional benefit

Brands

  • Camber Specialty: Specialty generic medications division supporting hospitals, clinics, government facilities, and institutional partners with high-quality generic choices including injectables and oncology medications
  • Camber Consumer Care

Products and services

  • Camber Pharmaceuticals (Rx Generics) Primary prescription generic pharmaceutical division offering a comprehensive portfolio of cost-effective generic medications across multiple therapeutic categories including cardiovascular, oncology, antiviral, neurological, and acute care treatments. Targeted at wholesalers, distributors, hospitals, and retail pharmacies.
  • Camber Specialty (Injectables and Oncology) Specialty pharmaceutical division focused on injectable and oncology medications, supporting hospitals, clinics, government facilities, and institutional partners with high-quality specialty generic choices.
  • Camber Consumer Care (OTC) Over-the-counter pharmaceutical division delivering high-quality OTC medications, providing focused and reliable supply of products to retail partners for consumer purchase.
  • Nitazoxanide Tablets Antiprotozoal medication indicated for treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum infections. Generic to Alinia. Available in 500mg strength, 6 count bottles.
  • Cisatracurium Besylate Injection, USP Nondepolarizing neuromuscular blocker indicated as adjunct to general anesthesia for tracheal intubation and skeletal muscle relaxation during surgery, and for mechanical ventilation in ICU. Generic to Nimbex.
  • Olmesartan Medoxomil and Hydrochlorothiazide Tablets Combination angiotensin II receptor blocker (ARB) and thiazide diuretic for treatment of hypertension to lower blood pressure and reduce risk of cardiovascular events. Generic to Benicar HCT.
  • Plerixafor Injection Hematopoietic stem cell mobilizer used with G-CSF to mobilize stem cells for collection and subsequent autologous transplantation in non-Hodgkin's lymphoma and multiple myeloma patients. Generic to Mozobil.
  • Sirolimus Oral Solution mTOR inhibitor immunosuppressant for prophylaxis of organ rejection in renal transplant patients aged 13 and older, used with cyclosporine and corticosteroids. Generic to Rapamune.
  • Avanafil Tablets Phosphodiesterase 5 (PDE5) inhibitor for treatment of erectile dysfunction. Generic to Stendra. Available in 50mg, 100mg, and 200mg strengths in 30 count bottles.
  • Erlotinib Tablets Kinase inhibitor for treatment of metastatic non-small cell lung cancer and pancreatic cancer (in combination with gemcitabine). Generic to Tarceva.
  • Capecitabine Tablets, USP Nucleoside metabolic inhibitor for adjuvant treatment of Stage III colon cancer, perioperative rectal cancer, and treatment of metastatic colorectal, breast, gastric, esophageal, gastroesophageal junction, and pancreatic cancers. Generic to Xeloda.
  • Decitabine for Injection Nucleoside metabolic inhibitor for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS. Generic to Dacogen.
  • Diatrizoate Meglumine and Diatrizoate Sodium Solution, USP Diagnostic contrast agent for radiographic examination of gastrointestinal tract segments and adjunct contrast enhancement in CT imaging. Generic to Gastrografin.
  • Copay Assistance Program Patient assistance program offering copay cards for select specialty medications including Dabigatran, Deferasirox, Dimethyl Fumarate, Droxidopa, Eltrombopag, Fingolimod, Lenalidomide, Nilotinib, Pirfenidone, Pomalidomide, Sapropterin, and Sodium Oxybate to reduce out-of-pocket costs.

Quantifiable outcome

  • Supply service levels consistently exceed 95% for primary positions
  • +3 more outcomes

Companies that use Camber Pharmaceuticals

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Camber Pharmaceuticals technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Camber Pharmaceuticals partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Hetero (Parent Company)coreStrategic or Co-development PartnerHetero is the parent company and strategic partner of Camber Pharmaceuticals. Hetero is one of the world's largest manufacturers of APIs and finished dosage forms, based in Hyderabad, India. Hetero provides Camber with vertical integration capabilities from KSMs to APIs to FDFs, R&D support with 1,200+ researchers, and access to 45 manufacturing facilities (8 dedicated to US market). Hetero employs 32,000+ associates and has presence in 140+ countries.
  • Clinton FoundationminorStrategic or Co-development PartnerHetero partnered with the Clinton Foundation to supply antiretroviral (ARV) medicines to underprivileged countries, particularly in Africa.
  • Healthcare Distribution PartnerscoreChannel Partner/ Reseller/ DistributorCamber works with healthcare distribution partners including major distributors to ensure reliable product availability and improve operational efficiency across the healthcare supply chain.
  • Ascent PharmaceuticalsminorStrategic or Co-development PartnerAscent Pharmaceuticals, Inc. of Central Islip, New York is Camber's sister company engaged in development and manufacturing of controlled substance generics including Oxycodone, Dronabinol, and Fentanyl products.

Scale indicators16 records

Recent moves7 records

Expansion highlights6 records

Camber Pharmaceuticals competitors and assessment

Company assessment

Broad incumbents

  • Teva Pharmaceutical Industries: The world's largest generic drug manufacturer with a broad US portfolio across oral solids, injectables, and specialty. Directly comparable because both compete head-to-head on Day-1 generic launches and institutional/wholesaler channels, though Teva operates at vastly larger global scale.
  • Sandoz (Novartis): Sandoz is one of the top global generic and biosimilar players with a large US generic portfolio, including injectables and oral solids. Highly comparable as both compete for Day-1 ANDA launches and wholesaler contracts; Sandoz also has vertically integrated manufacturing.
  • Viatris: Formed from the Mylan-Upjohn combination, Viatris is a major US generics supplier with a deep portfolio spanning retail, hospital, and specialty channels. Comparable because both companies sell broad-line generics through the same wholesalers and institutional buyers.

Direct peers

  • Apotex: Apotex is a privately held Canadian generic pharmaceutical manufacturer with significant US sales, vertically integrated API-to-FDF operations, and a broad product portfolio. Closely comparable to Camber given its private status, vertical integration, and aggressive ANDA pipeline.
  • Aurobindo Pharma USA: US arm of India's Aurobindo Pharma, supplying generics across oral solids, injectables, and specialty. Comparable to Camber given Indian-parent vertical integration model, broad US portfolio, and shared reliance on ANDA pipelines.
  • Sun Pharmaceutical Industries: Sun Pharma's US subsidiary (including the former Taro Pharmaceutical) supplies a broad range of generic Rx and specialty products. Highly comparable to Camber in business model, scale of US generics operations, and India-backed vertical integration.
  • Lupin Pharmaceuticals: Lupin's US business sells generic oral solids, injectables, and specialty products with strong institutional relationships. Comparable to Camber as both are India-headquartered generic companies focused on US Day-1 launches and high-ANDA approval velocity.
  • Dr. Reddy's Laboratories: Dr. Reddy's US generics arm supplies Rx, OTC, and specialty products across therapeutic categories including oncology and CNS. Comparable because both rely on parent-company vertical integration, broad ANDA pipelines, and large wholesaler relationships.
  • Zydus Pharmaceuticals (USA): Zydus is the US generics subsidiary of India's Cadila Healthcare, offering oral solids, injectables, and specialty generics. Comparable to Camber given shared India-parent structure, US Day-1 launch focus, and broad institutional/retail channels.

Regional players

  • Endo International: Endo's generics segment (including Par Pharmaceutical) supplies US generics, sterile injectables, and specialty products through institutional channels. Comparable to Camber in US generics and injectables exposure, though Endo has historically focused more on branded specialty and 505(b)(2) opportunities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Camber Pharmaceuticals social profiles

Digital presence

Camber Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Camber Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles7 records

Camber Pharmaceuticals subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Camber Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Camber Pharmaceuticals M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Camber Pharmaceuticals

What does Camber Pharmaceuticals do?

Camber Pharmaceuticals manufactures, markets, and distributes a portfolio of nearly 200 generic prescription (Rx), specialty, and over-the-counter (OTC) pharmaceutical products in the United States. The company operates three divisions—Camber Pharmaceuticals (Rx generics), Camber Specialty (injectables and oncology), and Camber Consumer Care (OTC)—supported by parent company Hetero's vertically integrated supply chain from key starting materials to active pharmaceutical ingredients to finished dosage forms.

Is Camber Pharmaceuticals a public or private company?

Camber Pharmaceuticals is a private company. It is classified as corporate owned and is currently operating.

When was Camber Pharmaceuticals founded?

Camber Pharmaceuticals was founded in 2007. It employs 101 to 250 people.

Where is Camber Pharmaceuticals based?

Camber Pharmaceuticals is headquartered in Piscataway, United States, in the North America region.

How does Camber Pharmaceuticals make money?

Three revenue lines are on record. Generic Rx Product Sales are the primary driver. The others are specialty Generic Products and over-the-Counter (OTC) Products.

Who are Camber Pharmaceuticals's main competitors?

Broad incumbents on record are Teva Pharmaceutical Industries, Sandoz (Novartis) and Viatris. Direct peers are Apotex, Aurobindo Pharma USA, Sun Pharmaceutical Industries, Lupin Pharmaceuticals, Dr. Reddy's Laboratories and Zydus Pharmaceuticals (USA). Endo International is listed as a regional player.

Does Camber Pharmaceuticals have an API?

No public API is recorded for Camber Pharmaceuticals.

What industry is Camber Pharmaceuticals in?

Camber Pharmaceuticals's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of HLAIADAB, Cold, Flu & Cough Remedies. Its NAICS code is 3254 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Drug Store NewsCamber releases generic ClomidCamber Pharmaceuticals launched generic clomiphene citrate tablets, a generic for Cosette Pharmaceuticals' Clomid, in 50-mg strengths. The company noted that 14-25% of women of reproductive age experience irregular menstrual cycles, which may be associated with hormonal imbalances and fertility challenges.Drug Store NewsCamber launches generic IsentressCamber Pharmaceuticals launched generic raltegravir 400mg tablets, the only available generic for Isentress. The 60-tablet bottles are backed by copay programs that can reduce out-of-pocket costs to $0 for eligible patients. The drug is indicated for HIV-1 treatment in adults and pediatric patients weighing at least 2 kg.Drug Store NewsHIV Treatment Becomes More AffordableCamber Pharmaceuticals launched a generic 400-mg Raltegravir option with copay programs to lower HIV treatment costs. The company's 180-day exclusivity begins November 1. WHO data shows AIDS-related deaths fell 73% since 2004, to 570,000 in 2023.Drug Store NewsCamber introduces generic SuboxoneCamber launched buprenorphine and naloxone sublingual films, a generic for Suboxone, in 30-pouch packages with strengths of 2/0.5, 4/1, 8/2, and 12/3 mg. The films are indicated for opioid dependence treatment and should be used with counseling and psychosocial support.Drug Store NewsCamber launches generic HyzaarCamber launched a generic version of Hyzaar, combining losartan potassium and hydrochlorothiazide, for treating hypertension and reducing cardiovascular risks. The product is available in three dosage strengths (50/12.5, 100/12.5, 100/25 mg) in 30, 90, and 1000-count packs. The company noted the stroke-reduction benefit has not been demonstrated in Black patients.Drug Store NewsCamber Specialty launches generic BridionCamber Specialty, a division of Camber Pharmaceuticals, has launched sugammadex injection, its first day 1 injectable product and a generic version of Bridion. The drug is indicated for the reversal of neuromuscular blockade in adult and pediatric patients 2 years and older undergoing surgery. The product is available in two dosage strengths packaged as single-dose vials.CBS NewsCamber Pharmaceuticals recalls pneumonia medication due to heart riskCamber Pharmaceuticals recalled Atovaquone Oral Suspension lot #E220182 due to potential Bacillus cereus contamination, which can cause endocarditis. The company reported no illnesses from the batch, and the FDA advised retailers to stop using or selling the product.NJBIZCamber Pharmaceuticals recalls pneumonia medicationCamber Pharmaceuticals recalled lot E220182 of Atovaquone Oral Suspension, USP 750mg/5mL, due to potential Bacillus cereus contamination. The recall affects immunocompromised patients and has not resulted in adverse event reports. The company is notifying distributors and pharmacies for returns.FiercePharmaSun, Camber join growing list of companies reporting Adderall supply problemsCamber Pharmaceuticals and Sun Pharma joined the list of companies reporting Adderall supply problems, according to the University of Utah Pharmacy Services. Sandoz, the nation's second-largest Adderall supplier, is also running low on immediate-release versions. The shortage has persisted since 2019, with seven of nine U.S. suppliers now reporting issues.The Epoch TimesFDA Alert: Legacy Pharmaceutical Recalls More Losartan TabletsLegacy Pharmaceutical is recalling 40 lots of Losartan tablets after trace amounts of NMBA, a potentially carcinogenic compound, were found. The recall follows a voluntary recall by Camber Pharmaceuticals of the same medication. Consumers are advised to contact their pharmacy or physician if they have experienced problems.